'Biosimilar V. Biosimilar' Patent Case May Be First Of Many
On Jan. 24, 2019, Coherus BioSciences Inc. filed a complaint against Amgen Inc. in the U.S. District Court for the District of Delaware. alleging infringement of three related patents directed to...To view the full article, register now.
Already a subscriber? Click here to view full article